MAPK8 and diabetes mellitus: The JNK pathway is implicated in diabetes [7], inflammatory bowel disease [8], cardiovascular disease [9], cancer [10,11], and others, where the loss of JNK signaling results in the inhibition of tumor necrosis factor (TNF)-stimulated cell death [12].